Natália C. Salazar

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein

R. Gazzinelli, S. Ramos, J. Kalil, 2022, Nature Communications.

Neutralizing antibody-independent immunity to SARS-CoV-2 in Syrian hamsters and human ACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein

R. Gazzinelli, S. Ramos, J. Kalil, 2021 .

Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein

O. Caballero, R. Gazzinelli, S. Ramos, 2021, bioRxiv.

Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA

Young Chan Kim, F. D. da Fonseca, A. Reyes-Sandoval, 2020, Viruses.

DUPLICATE: DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19

R. Gazzinelli, C. Soares, A. Ferreira, 2022, Journal of Clinical Virology Plus.

Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19

R. Gazzinelli, C. Soares, E. D. da Silva, 2021, Journal of Clinical Virology Plus.

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease

C. Carneiro, R. Gazzinelli, A. B. Reis, 2023, NPJ vaccines.

DUPLICATE: DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19

R. Gazzinelli, C. Soares, A. Ferreira, 2022, Journal of Clinical Virology plus.